HDAC9 and plasma cell myeloma: As pan-HDAC inhibitors have proven beneficial in the treatment of myeloma, we hypothesized that tropolones would have cytotoxic affects in myeloma cells but in a manner which may be dissimilar from the pan-HDAC inhibition.